Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medtronic PLC (MDT) vs Sony Group Corp (SONY) Price & Performance

Medtronic PLCTrade
Sony Group CorpTrade

Price performance (Past 24H)

Key statistics

Medtronic PLC vs Sony Group Corp — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Sony Group Corp trades at $24.12 (market cap $136.87B). The key difference: Sony Group Corp is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Sony Group Corp for 96 Days on average.

MDTSONY
Market Cap
$112.24B$136.87B
Volume
105,663,2365,364,503
Sector
HealthTechnology
52-Week High
$105.35$30.26
52-Week Low
$73.75$19.32
Typical Hold Time
63 Days96 Days
Enterprise Value
$131.58B$134.77B
Dividend Yield
3.28%0.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medtronic PLC

Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.

Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.

Sony Group Corp

Sony trades at $23.95, up 1.83% with bullish technical signals from moving averages. The company shows strong operating cash flow of $2.32T in 2025 and has beaten earnings expectations in two of the last three quarters. Analyst consensus is strongly positive with 11 buy ratings and no sell recommendations. Recent news highlights Sony's content strength and AI-related legal actions against Anthropic.

While Sony demonstrates financial strength with improving cash flow and revenue growth, investors face risks from projected 2026 net losses and competitive pressures. The stock's current valuation appears reasonable with P/E of 20.34, but margin compression and content industry disruption require careful monitoring for sustained shareholder value.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDT
6% Buy94% Sell
Avg holding period · 63 Days
SONY
2% Buy98% Sell
Avg holding period · 96 Days

Top news

Latest headlines on both assets

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →

About Sony Group Corp

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.

Read more on SONY →